DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

00460 SIHUAN PHARM

Closed Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. M & S Index, HS Comp.SmallCap Ind, Stock Connect HK Ind, Stock Connect HK MS, Stock Connect HK S I
Major Shareholders Che Fengsheng (36.85%)
Guo Weicheng (12.10%)
Sector Health Care & Biotechnology
Web Site http://www.sihuanpharm.com Tel (852) 3628-3911
Email IR@sihuanpharm.com Fax N/A
Related Equities N/A
Principal Activities The principal activities are research and development (“R&D”), and the manufacture and sale of pharmaceutical products in the People’s Republic of China (the “PRC”).

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
孟憲慧 5,930,498,699(L)  62.62(L)  11/01/2019
張炯龍 5,930,498,699(L)  62.62(L)  11/01/2019
車馮升 5,930,498,699(L) 8,155,661(S)  62.62(L) 0.09(S)  11/01/2019
郭維城 5,930,498,699(L)  62.62(L)  11/01/2019
UBS TC (Jersey) Ltd 5,907,898,697(L)  62.38(L)  17/07/2018
UBS Trustees (Cayman) Ltd. 5,907,542,365(L)  62.37(L)  10/10/2018
Mingyao Capital Limited 5,907,274,699(L)  62.37(L)  15/10/2018
Proper Process International Limited 5,907,274,699(L)  62.37(L)  15/10/2018
Successmax Global Holdings Limited 5,907,274,699(L)  62.37(L)  15/10/2018
Victory Faith International Limited 5,907,274,699(L)  62.37(L)  15/10/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
張炯龍 5,930,498,699(L)  62.62(L)  11/01/2019
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top